{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-182808","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2023-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.202000+00:00","generated_at":"2026-06-13T12:19:08.669920+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TherapeuticsMD issues 312,525 shares to Rubric Capital for $1.15M; amends bylaws","bullets":["Issued 312,525 shares at $3.6797/share to Rubric Capital Management on June 29, 2023, gross proceeds $1,149,998.","Stockholders approved the Subscription Agreement at the June 26, 2023 annual meeting under Nasdaq rules.","Board amended bylaws to exempt the Rubric Capital deal from Nevada control share acquisition statutes.","Shares sold in private placement exempt from registration under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-182808","json":"https://secwatch.observer/filing/0001193125-23-182808.json","markdown":"https://secwatch.observer/filing/0001193125-23-182808.md","text":"https://secwatch.observer/filing/0001193125-23-182808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312523182808/0001193125-23-182808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312523182808/d816117d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:19:08.669920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba5ffdcd19f31e29ce8d017a09e323860f2adcb4","claim":"TherapeuticsMD, Inc.: An amendment to the bylaws was adopted to opt out of Nevada's control share acquisition statutes with respect to the Subscription Agreement and related transactions (effective 2023-06-29).","evidence_excerpt":"Amendment to the Bylaws Effective June 29, 2023, the Board of Directors of the Company adopted and approved an amendment to the Bylaws of the Company, as previously amended (the “Bylaw Amendment”), to render the provisions of Nevada’s acquisition of controlling interest statutes (NRS 78.378 through 78.3793, inclusive) not applicable to the Subscription Agreement, the acquisition of any shares of the Company’s capital stock thereunder or the consummation of any transactions contemplated thereby, or by the other documents, instruments and arrangements contemplated by the Subscription Agreement.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000119312523182808/0001193125-23-182808-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-06-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}